Company: GRCE
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001140361-25-030398
Chunk: 48

Company: Grace Therapeutics, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Item 8
Chunk 48
---
 2025-04-01
    2025-06-30

    0001444192
    
      us-gaap:GeneralAndAdministrativeExpenseMember
      grce:EquityIncentivePlan2024Member

    2024-04-01
    2024-06-30

    0001444192
    
      grce:EquityIncentivePlan2024Member

    2025-04-01
    2025-06-30

    0001444192
    
      grce:EquityIncentivePlan2024Member

    2024-04-01
    2024-06-30

    0001444192
    
      us-gaap:EmployeeStockOptionMember

    2025-04-01
    2025-06-30

    0001444192
    
      us-gaap:EmployeeStockOptionMember

    2024-04-01
    2024-06-30

    0001444192
    
      grce:September2023CommonWarrantsMember

    2025-04-01
    2025-06-30

    0001444192
    
      grce:September2023CommonWarrantsMember

    2024-04-01
    2024-06-30

    0001444192
    
      grce:February2025CommonWarrantsMember

    2025-04-01
    2025-06-30

    0001444192
    
      grce:February2025CommonWarrantsMember

    2024-04-01
    2024-06-30

    0001444192
    
      us-gaap:OperatingSegmentsMember

    2025-04-01
    2025-06-30

    0001444192
    
      us-gaap:OperatingSegmentsMember

    2024-04-01
    2024-06-30

    0001444192
    
      grce:ContractManufacturingOrganizationsMember

    2025-06-30

  xbrli:shares

  iso4217:USD

      iso4217:USD

      xbrli:shares

  xbrli:pure

  grce:Segment